Development and Characterization of Innovative Multidrug Nanoformulation for Cardiac Therapy

For several decades, various peptides have been under investigation to prevent ischemia/reperfusion (I/R) injury, including cyclosporin A (CsA) and Elamipretide. Therapeutic peptides are currently gaining momentum as they have many advantages over small molecules, such as better selectivity and lowe...

Descripción completa

Detalles Bibliográficos
Autores principales: Gendron, Amandine, Domenichini, Séverine, Zanna, Sandrine, Gobeaux, Frédéric, Piesse, Christophe, Desmaële, Didier, Varna, Mariana
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10003764/
https://www.ncbi.nlm.nih.gov/pubmed/36902927
http://dx.doi.org/10.3390/ma16051812

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10003764/
https://www.ncbi.nlm.nih.gov/pubmed/36902927
http://dx.doi.org/10.3390/ma16051812

Ejemplares similares